Alnylam Pharmaceuticals, Inc.
REVERSIR TM COMPOUNDS
Last updated:
Abstract:
The present invention relates, in general to agents that modulate the pharmacological activity of conjugated siRNAs.
Status:
Application
Type:
Utility
Filling date:
10 Aug 2021
Issue date:
18 Aug 2022